{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:40:04Z","timestamp":1789656004233,"version":"4.0.1"},"reference-count":122,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2025,5,31]]},"DOI":"10.5582\/irdr.2025.01028","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T22:07:39Z","timestamp":1748556459000},"page":"109-121","source":"Crossref","is-referenced-by-count":6,"title":["Traditional Chinese medicine for intractable and rare diseases: Research progress and future strategies"],"prefix":"10.5582","volume":"14","author":[{"given":"Yuanzheng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, Medical College, Qinghai University, Xining, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Medical College, Qinghai University, Xining, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Song","sequence":"additional","affiliation":[{"name":"Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","unstructured":"1. Plaiasu V, Nanu M, Matei D. Rare disease day - At a glance. Maedica. 2010; 5:65-66."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sequeira AR, Mentzakis E, Archangelidi O, Paolucci F. The economic and health impact of rare diseases: A meta-analysis. Health Policy Technol. 2021; 10:32-44.","DOI":"10.1016\/j.hlpt.2021.02.002"},{"key":"3","unstructured":"3. European Union. Medicines for rare diseases - orphan drugs. <i>https:\/\/eur-lex.europa.eu\/EN\/legal-content\/summary\/medicines-for-rare-diseases-orphan-drugs.html<\/i> (accessed May 8, 2025)."},{"key":"4","unstructured":"4. U.S. Food and Drug Administration. Rare diseases at FDA. <i>https:\/\/www.fda.gov\/patients\/rare-diseases-fda<\/i> (accessed May 12, 2025)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lu Y, Han J. The definition of rare disease in China and its prospects. Intractable Rare Dis Res. 2022; 11:29-30.","DOI":"10.5582\/irdr.2022.01034"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wang Y, Liu Y, Du G, Liu Y, Zeng Y. Epidemiology and distribution of 207 rare diseases in China: A systematic literature review. Intractable Rare Dis Res. 2024; 13:73-88.","DOI":"10.5582\/irdr.2024.01001"},{"key":"7","unstructured":"7. The State Council of the People&apos;s Republic of China. Progress made in rare disease treatment. <i>https:\/\/english.www.gov.cn\/statecouncil\/ministries\/202211\/04\/content_WS63647e18c6d0a757729e249f.html<\/i> (accessed May 8, 2025)."},{"key":"8","unstructured":"8. Ministry of Science and Technology of the People&apos;s Republic of China. The project for &quot;China Rare Disease Prevention Research and Demonstration &quot; under the National Science and Technology Support Program of the 12th Five-Year Plan has passed final acceptance. <i>https:\/\/www.most.gov.cn\/kjbgz\/201607\/t20160726_126785.html<\/i> (accessed May 12, 2025)"},{"key":"9","unstructured":"9. Xu HP, Zhu C, Gong MC, Zhang SY. Research of rare diseases in China: From the past to the future. Med J Peking Union Med Coll Hosp. 2018; 9:5-9. (in Chinese)"},{"key":"10","unstructured":"10. Beijing Association of Rare Disease Diagnosis, Treatment and Security. About us. <i>https:\/\/www.chard.org.cn\/about<\/i> (accessed May 8, 2025)."},{"key":"11","unstructured":"11. China Pharmaceutical Innovation and Research Development Association. Bright Prospects for the big health industry: Traditional Chinese medicine sales to account for 32.4% of the pharmaceutical market by 2020. <i>https:\/\/www.phirda.com\/about_19001.html<\/i> (accessed May 12, 2025)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Somekawa L, Maegawa H, Tsukada S, Nakamura T. Establishment of application guidance for OTC non-kampo crude drug extract products in Japan. J Intercult Ethnopharmacol. 2017; 6:333-338.","DOI":"10.5455\/jice.20170713091550"},{"key":"13","unstructured":"13. The Central People&apos;s Government of the People&apos;s Republic of China. Notice of the General Office of the State Council on Issuing the &quot;14th Five-Year Plan for the Development of Traditional Chinese Medicine&quot;. <i>https:\/\/www.gov.cn\/zhengce\/zhengceku\/2022-03\/29\/content_5682255.htm<\/i> (accessed May 12, 2025)."},{"key":"14","unstructured":"14. The Central People&apos;s Government of the People&apos;s Republic of China. Notice of the General Office of the State Council on issuing the implementation plan for major projects in the revitalization and development of traditional Chinese medicine. <i>https:\/\/www.gov.cn\/zhengce\/zhengceku\/2023-02\/28\/content_5743680.htm<\/i> (accessed May 12, 2025)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G. Amyotrophic lateral sclerosis. Lancet. 2022; 400:1363-1380.","DOI":"10.1016\/S0140-6736(22)01272-7"},{"key":"16","unstructured":"16. Napattharin V, Natkitta S, Han XJ, Li R, Zhang HH, Wang CH, Pan WD. New progress in the etiology and treatment of amyotrophic lateral sclerosis with traditional Chinese and Western medicine. J Neurol Neurorehab. 2024; 20:47-57. (in Chinese)"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liu X, Qin T, Li T, Shan L, Lei X, Xu X, Wen B, Feng Y, Yin P, Fan D. &quot;Huoling shengji granule&quot; for amyotrophic lateral sclerosis: Protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial. Front Aging Neurosci. 2023; 15:1153973.","DOI":"10.3389\/fnagi.2023.1153973"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhou Q, Wang Y, Zhang J, Shao Y, Li S, Wang Y, Cai H, Feng Y, Le W. Fingerprint analysis of Huolingshengji Formula and its neuroprotective effects in SOD1G93A mouse model of amyotrophic lateral sclerosis. Sci Rep. 2018; 8:1668.","DOI":"10.1038\/s41598-018-19923-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Huang GC, Lee CJ, Wang KT, Weng BC, Chien TY, Tseng SH, Wang CC. Immunomodulatory effects of hedysarum polybotrys extract in mice macrophages, splenocytes and leucopenia. Molecules. 2013; 18:14862-14875.","DOI":"10.3390\/molecules181214862"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Han R, Tang F, Lu M, Xu C, Hu J, Mei M, Wang H. Astragalus polysaccharide ameliorates H2O2-induced human umbilical vein endothelial cell injury. Mol Med Rep. 2017; 15:4027-4034.","DOI":"10.3892\/mmr.2017.6515"},{"key":"21","unstructured":"21. Lin S, Ye S, Huang J, Tian Y, Xu Y, Wu M, Wang J, Wu S, Cai J. How do Chinese medicines that tonify the kidney inhibit dopaminergic neuron apoptosis? Neural Regener Res. 2013; 8:2820-2826."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Raman C, McAllister SD, Rizvi G, Patel SG, Moore DH, Abood ME. Amyotrophic lateral sclerosis: Delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5:33-39.","DOI":"10.1080\/14660820310016813"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bilsland LG, Dick JR, Pryce G, Petrosino S, Di Marzo V, Baker D, Greensmith L. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB J. 2006; 20:1003-1005.","DOI":"10.1096\/fj.05-4743fje"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020; 172:ITC81-96.","DOI":"10.7326\/AITC202006020"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wang H, Li M, Zou K, Wang Y, Jia Q, Wang L, Zhao J, Wu C, Wang Q, Tian X, Wang Y, Zeng X. Annual direct cost and cost-drivers of systemic lupus erythematosus: A multi-center cross-sectional study from CSTAR registry. Int J Environ Res Public Health. 2023; 20:3522.","DOI":"10.3390\/ijerph20043522"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wang Y, Han M, Pedigo CE, Xie ZM, Wang WJ, Liu JP. Chinese herbal medicine for systemic lupus erythematosus: A systematic review and meta-analysis of randomized, placebo-controlled trials. Chin J Integr Med. 2021; 27:778-787.","DOI":"10.1007\/s11655-021-3497-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Li D, Pan B, Ma N, Wang X, Deng X, Lai H, Ge L, Niu J, Yang K. Efficacy and safety of shenqi dihuang decoction for lupus nephritis: A systematic review and meta-analysis. J Ethnopharmacol. 2024; 323:117602.","DOI":"10.1016\/j.jep.2023.117602"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Chen HQ, Zhang N, Li CX, Zhang HX. Effects of astragalus membranaceus on systemic lupus erythematosus in a mouse model of pregnancy. Immun Inflammation Dis. 2022; 10:e624.","DOI":"10.1002\/iid3.624"},{"key":"29","unstructured":"29. Chae BS, Yang JH. Regulatory effect of fresh Rehmanniae Radix extract on the <i>in vitro<\/i> production of proinflammatory cytokines in pristane-induced lupus mice. Nat Prod Sci. 2007; 13:322-327."},{"key":"30","unstructured":"30. Li M, Ma JJ, Zhao XL, Zhu Y. Treating lupus nephritis by a drug pair of Radix Astragali and Rehmanniae Radix combined with glucocorticoid: A preliminary clinical study. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014; 34:956-959. (in Chinese)"},{"key":"31","unstructured":"31. Pollard KM, Cauvi DM, Toomey CB, Morris KV, Kono DH. Interferon-\u03b3 and systemic autoimmunity. Discov Med. 2013; 16:123-131."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Billiau A. Interferon-gamma: Biology and role in pathogenesis. Adv Immunol. 1996; 62:61-130.","DOI":"10.1016\/S0065-2776(08)60428-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hu H, Chen E, Li Y, Zhu X, Zhang T, Zhu X. Effects of arsenic trioxide on INF-gamma gene expression in MRL\/lpr mice and human lupus. Biol Trace Elem Res. 2018; 184:391-397.","DOI":"10.1007\/s12011-017-1206-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Chen C, Zhu R, Liu M, Yang H, Guo F, Du Q, Wang X, Li M, Song G, Qin R, Liu S. Kunxian capsule alleviates renal damage by inhibiting the JAK1\/STAT1 pathway in lupus nephritis. J Ethnopharmacol. 2023; 310:116349.","DOI":"10.1016\/j.jep.2023.116349"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Chen Y, Wang YF, Song SS, Zhu J, Wu LL, Li XY. Potential shared therapeutic and hepatotoxic mechanisms of tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation. J Ethnopharmacol. 2022; 296:115496.","DOI":"10.1016\/j.jep.2022.115496"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. DiMauro S, Hirano M. Mitochondrial encephalomyopathies: An update. Neuromuscul Disord. 2005; 15:276-286.","DOI":"10.1016\/j.nmd.2004.12.008"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Lorenzoni PJ, Werneck LC, Kay CSK, Silvado CES, Scola RH. When should MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) be the diagnosis? Arq Neuropsiquiatr. 2015; 73:959-967.","DOI":"10.1590\/0004-282X20150154"},{"key":"38","unstructured":"38. Long H, Huang L, Wang J, Li Y, Fu X, Wen C. Mitochondrial encephalomyopathy involves ophthalmology, otorhinolaryngology, neurology and their clinical features. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021; 35:529-534. (in Chinese)"},{"key":"39","unstructured":"39. Li Y, Gu X, Li J. Clinical analysis of the opposite and complementary method for treating mitochondrial encephalomyopathy. Chin J Clin Pharmacol. 2015; 31:890-892. (in Chinese)"},{"key":"40","unstructured":"40. Qiu Q. Neuroprotective effects of salidroside on GSK-3\u03b2 in rats with cerebral ischemia\/reperfusion. Chin Pharmacol Bull. 2020; 665-669."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Huang B. Research progress on Traditional Chinese medicine treatment of Parkinson&apos;s disease. Hans J Med Chem. 2019; 7:57-63. (in Chinese)","DOI":"10.12677\/HJMCe.2019.74010"},{"key":"42","unstructured":"42. Su X, Guo C, Ying Q, Zhou D. Differentiation and treatment of mitochondrial encephalomyopathy based on the theory of Rong Qi deficiency. Clin J Trad Chin Med. 2021; 33:2266-2269. (in Chinese)"},{"key":"43","unstructured":"43. Chen ZG, Wang Y, Li NN, Ren S, Chen L, Kang SH, Ran WZ, Zhang XN, Zhao D. Treatment of mitochondrial encephalomyopathy based on the theory of &quot;brain Qi - brain spirit - brain marrow.&quot; Chin J Integrative Med Cardio\/Cerebrovasc Dis. 2023; 21:3649-3652. (in Chinese)"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Young NS. Aplastic anemia. N Engl J Med. 2018; 379:1643-1656.","DOI":"10.1056\/NEJMra1413485"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Marsh JC. Treatment of aplastic anaemia: First do no harm. Lancet. 2000; 356:1536-1537.","DOI":"10.1016\/S0140-6736(00)03117-2"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017; 129:1428-1436.","DOI":"10.1182\/blood-2016-08-693481"},{"key":"47","unstructured":"47. Hu ZJ, Zhang XM, Lan HX, Wu J, Zhu LL. Efficacy and safety of therapy of tonifying kidney and promoting blood circulation combined with cyclosporine plus androgen for the treatment of aplastic anemia: A meta-analysis. J Guangzhou Univ Tradit Chin Med.. 2024; 41:1919-1926. (in Chinese)"},{"key":"48","unstructured":"48. Song XY, He DD, Wang JH, Sun WZ. Meta-analysis of traditional Chinese medicine combined with IST regimen in the treatment of aplastic anemia. Yunnan J Trad Chin Med and Materia Medica. 2025; 46:63-69. (in Chinese)"},{"key":"49","unstructured":"49. Zhu C, Gao Y, Jiang T, Hao C, Gao Z, Sun Y. Meta-analysis of huangqi injection for the adjunctive therapy of aplastic anemia. Int J Clin Exp Med. 2015; 8:10256-10264."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Deng P, Li X, Wei Y, Liu J, Chen M, Xu Y, Dong B, Zhu L, Chai L. The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model. PLoS One. 2017; 12:e0180417.","DOI":"10.1371\/journal.pone.0180417"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Wang MS, Li J, Di HX, Li ZL, Yang SL, Hou W, Yan JY, Zhao XM. Clinical study on effect of Astragalus Injection and its immuno-regulation action in treating chronic aplastic anemia. Chin J Integr Med. 2007; 13:98-102.","DOI":"10.1007\/s11655-007-0098-5"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Chiu ML, Hsu YL, Chen CJ, Li TM, Chiou JS, Tsai FJ, Lin TH, Liao CC, Huang SM, Chou CH, Liang WM, Lin YJ. Chinese herbal medicine therapy reduces the risks of overall and anemia-related mortalities in patients with aplastic anemia: A nationwide retrospective study in Taiwan. Front Pharmacol. 2021; 12:730776.","DOI":"10.3389\/fphar.2021.730776"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Jiang ZY, Yu FQ, Gao RL, Kuang YM, Zhu Y, Chen YH, Li LJ, Ouyang GF, Hu J, Wu XL. Treatment of chronic aplastic anemia with Chinese patent medicine Pai-Neng-Da capsule for replacing androgen partially: A clinical multi-center study. Chin J Integr Med. 2022; 28:20-27.","DOI":"10.1007\/s11655-021-3283-z"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Wen WW, Sun X, Zhuang HF, Lin XJ, Zheng ZY, Gao RL, Yin LM. Effects of panaxadiol saponins component as a new Chinese patent medicine on proliferation, differentiation and corresponding gene expression profile of megakaryocytes. Chin J Integr Med. 2016; 22:28-35.","DOI":"10.1007\/s11655-015-1970-3"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Zheng ZY, Yu XL, Dai TY, Yin LM, Zhao YN, Xu M, Zhuang HF, Chong BH, Gao RL. Panaxdiol saponins component promotes hematopoiesis and modulates T lymphocyte dysregulation in aplastic anemia model mice. Chin J Integr Med. 2019; 25:902-910.","DOI":"10.1007\/s11655-019-3049-z"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Bandmann O, Weiss KH, Kaler SG. Wilson&apos;s disease and other neurological copper disorders. Lancet, Neurol. 2015; 14:103-113.","DOI":"10.1016\/S1474-4422(14)70190-5"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Wright LM, Huster D, Lutsenko S, Wrba F, Ferenci P, Fimmel CJ. Hepatocyte GP73 expression in Wilson disease. J Hepatol. 2009; 51:557-564.","DOI":"10.1016\/j.jhep.2009.05.029"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Hedera P. Update on the clinical management of Wilson&apos;s disease. Appl Clin Genet. 2017; 10:9-19.","DOI":"10.2147\/TACG.S79121"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. European Association for Study of Liver. EASL clinical practice guidelines: Wilson&apos;s disease. J Hepatol. 2012; 56:671-685.","DOI":"10.1016\/j.jhep.2011.11.007"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Xu MB, Rong PQ, Jin TY, Zhang PP, Liang HY, Zheng GQ. Chinese herbal medicine for Wilson&apos;s disease: A systematic review and meta-analysis. Front Pharmacol. 2019; 10:277.","DOI":"10.3389\/fphar.2019.00277"},{"key":"61","unstructured":"61. Fang X, Jin S, Yang W, Chen H, Fu Y. Clinical study of Gandou Decoction combined with copper-removal therapy for balance disorder in patients with interior retention of damp-heat type Wilson&apos;s disease. Chinese General Practice. 2020; 23:3094-3098. (in Chinese)"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Hwang JK, Noh EM, Moon SJ, Kim JM, Kwon KB, Park BH, You YO, Hwang BM, Kim HJ, Kim BS, Lee SJ, Kim JS, Lee YR. Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice. Rheumatology (Oxford). 2013; 52:1583-1591.","DOI":"10.1093\/rheumatology\/ket178"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Shia CS, Juang SH, Tsai SY, Chang PH, Kuo SC, Hou YC, Chao PD. Metabolism and pharmacokinetics of anthraquinones in rheum palmatum in rats and ex vivo antioxidant activity. Planta Med. 2009; 75:1386-1392.","DOI":"10.1055\/s-0029-1185725"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Jin H, Sakaida I, Tsuchiya M, Okita K. Herbal medicine rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Life Sci. 2005; 76:2805-2816.","DOI":"10.1016\/j.lfs.2004.09.041"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Yi J, Wu S, Tan S, Qin Y, Wang X, Jiang J, Liu H, Wu B. Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis. Cell Death Discov. 2021; 7:374.","DOI":"10.1038\/s41420-021-00768-7"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Chai FN, Zhang J, Xiang HM, Xu HS, Li YF, Ma WY, Li XG, Ye XL. Protective effect of coptisine from rhizoma coptidis on LPS\/D-GalN-induced acute liver failure in mice through up-regulating expression of miR-122. Biomed Pharmacother. 2018; 98:180-190.","DOI":"10.1016\/j.biopha.2017.11.133"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Chen Y, Zhang B, Cao S, Huang W, Liu N, Yang W. GanDouLing combined with penicillamine improves cerebrovascular injury <i>via<\/i> PERK\/eIF2\u03b1\/CHOP endoplasmic reticulum stress pathway in the mouse model of Wilson&apos;s disease. Biosci Rep. 2018; 38:BSR20180800.","DOI":"10.1042\/BSR20180800"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Fang S, Yang W, Zhang K, Peng C. Gandouling mitigates CuSO4-induced heart injury in rats. Animals (Basel). 2022; 12:2703.","DOI":"10.3390\/ani12192703"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Cheng C, Wang Q, Huang Y, Xue Q, Wang Y, Wu P, Liao F, Miao C. Gandouling inhibits hepatic fibrosis in Wilson&apos;s disease through wnt-1\/\u03b2-catenin signaling pathway. J Ethnopharmacol. 2023; 311:116445.","DOI":"10.1016\/j.jep.2023.116445"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Zhou Y, Wu R, Cai FF, Zhou WJ, Lu YY, Zhang H, Chen QL, Sun MY, Su SB. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone a, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis. Pharm Biol. 2021; 59:1594-1606.","DOI":"10.1080\/13880209.2021.1999275"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Luo Y, Huo Y, Song P, Zhang X, Liao M. Validation and functional analysis of the critical proteins in combination with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats. Biomed Pharmacother. 2019; 115:108975.","DOI":"10.1016\/j.biopha.2019.108975"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Jiang J, Wang Y, Deng M. New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022. Front Pharmacol. 2022; 13:1054006.","DOI":"10.3389\/fphar.2022.1054006"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Blair HA. Tofersen: First approval. Drugs. 2023; 83:1039-1043.","DOI":"10.1007\/s40265-023-01904-6"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Aschenbrenner DS. New drug approved for ALS. Am J Nurs. 2023; 123:22-23.","DOI":"10.1097\/01.NAJ.0000911516.31267.67"},{"key":"75","unstructured":"75. Neurologylive. Amylyx pharmaceuticals discontinues AMX0035 after failing primary end point in phase 3 PHOENIX trial. <i>https:\/\/www.neurologylive.com\/view\/amylyx-pharmaceuticals-discontinues-amx0035-after-failing-primary-end-point-phase-3-phoenix-trial<\/i> (accessed May 12, 2025)."},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Balendra R, Al Khleifat A, Fang T, Al-Chalabi A. A standard operating procedure for King&apos;s ALS clinical staging. Amyotroph Lateral Scler Front Degener. 2019; 20:159-164.","DOI":"10.1080\/21678421.2018.1556696"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Qiu H, Li JH, Yin SB, Ke JQ, Qiu CL, Zheng GQ. Dihuang yinzi, a classical Chinese herbal prescription, for amyotrophic lateral sclerosis: A 12-year follow-up case report. Medicine (Baltimore). 2016; 95:e3324.","DOI":"10.1097\/MD.0000000000003324"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. de Carvalho M, Swash M, Pinto S. Diaphragmatic neurophysiology and respiratory markers in ALS. Front Neurol. 2019; 10:143.","DOI":"10.3389\/fneur.2019.00143"},{"key":"79","unstructured":"79. Wanfangdata. Clinical assessment of bulbar palsy in amyotrophic lateral sclerosis and therapeutic effect of spleen-strengthening and lung-tonifying formula. <i>https:\/\/d.wanfangdata.com.cn\/thesis\/Y3144311<\/i> (accessed May 12, 2025)."},{"key":"80","unstructured":"80. Bao J, Fu M, Shen B, Zhu X. Clinical study of Jiawei Sijunzi Decoction in the treatment of amyotrophic lateral sclerosis. Herald Med. 2016; 35:43\u201345. (in Chinese)"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Yang Z, Sun R, Tian Y, Zhang Y, Li Y, Wang Q. The correlation study between traditional Chinese medicine constitutions and immunology. Immunol Stud. 2014; 2:23-32. (in Chinese)","DOI":"10.12677\/IS.2014.23005"},{"key":"82","unstructured":"82. Deng YF, Li MD, Liu DY, Zhao HM, Zhou W. A review on immunopharmacological mechanism and clinical application of the Buzhong Yiqi decoction. Clin J Chin Med. 2023; 15:68-72. (in Chinese)"},{"key":"83","unstructured":"83. Wu YL. Correlation analysis of Qi collateral\u2013NEI network. J Trad Chin Med. 2005; 16:723-726. (in Chinese)"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Cui C, Ingre C, Yin L, Li X, Andersson J, Seitz C, Ruffin N, Pawitan Y, Piehl F, Fang F. Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis. Elife. 2022; 11:e74065.","DOI":"10.7554\/eLife.74065"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020; 11:279.","DOI":"10.3389\/fneur.2020.00279"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Sugimoto K, Liu J, Li M, Song Y, Zhang C, Zhai Z, Gao Y. Neuroprotective effects of shenqi fuzheng injection in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis. Front Pharmacol. 2021; 12:701886.","DOI":"10.3389\/fphar.2021.701886"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Cai M, Lee SH, Yang EJ. Bojungikgi-tang improves muscle and spinal cord function in an amyotrophic lateral sclerosis model. Mol Neurobiol. 2019; 56:2394-2407.","DOI":"10.1007\/s12035-018-1236-0"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Zhang WB, Tian YY, Li H, Tian JH, Luo MF, Xu FL, Wang GJ, Huang T, Xu YH, Wang RH. A discovery of low hydraulic resistance channel along meridians. J Acupunct Meridian Stud. 2008; 1:20-28.","DOI":"10.1016\/S2005-2901(09)60003-0"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Yang J, Zuo, Shi Y. Research progress on physiological basis and physical characteristics of meridians. Tradit Chin Med. 2022; 11:641-647. (in Chinese)","DOI":"10.12677\/TCM.2022.114091"},{"key":"90","unstructured":"90. Deng WL. Advances in research on traditional Chinese medicine for amyotrophic lateral sclerosis (part II). Pharmacol Clinics Chin Materia Medica. 2016; 32:233-243. (in Chinese)"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Taylor JP, Brown RH, Cleveland DW. Decoding ALS: From genes to mechanism. Nature. 2016; 539:197-206.","DOI":"10.1038\/nature20413"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Van Damme P, Robberecht W, Van Den Bosch L. Modelling amyotrophic lateral sclerosis: progress and possibilities. Dis Models Mech. 2017; 10:537-549.","DOI":"10.1242\/dmm.029058"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Tian W, Zhao J, Lee JH, Akanda MR, Cho JH, Kim SK, Choi YJ, Park BY. Neuroprotective effects of cornus officinalis on stress-induced hippocampal deficits in rats and H2O2-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Antioxid (basel Switz). 2019; 9:27.","DOI":"10.3390\/antiox9010027"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Mikami M, Takuya O, Yoshino Y, Nakamura S, Ito K, Kojima H, Takahashi T, Iddamalgoda A, Inoue S, Shimazawa M, Hara H. Acorus calamus extract and its component \u03b1-asarone attenuate murine hippocampal neuronal cell death induced by l-glutamate and tunicamycin. Biosci Biotechnol Biochem. 2021; 85:493-501.","DOI":"10.1093\/bbb\/zbaa071"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Xu X, Zhang C, Wang N, Xu Y, Tang G, Xu L, Feng Y. Bioactivities and mechanism of actions of <i>Dendrobium officinale<\/i>: A comprehensive review. Oxid Med Cell Longev. 2022; 2022:6293355.","DOI":"10.1155\/2022\/6293355"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Zeng KW, Zhang T, Fu H, Liu GX, Wang XM. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the toll-like receptor 4-dependent MyD88\/IKK\/NF-\u03baB signaling pathway in lipopolysaccharide-induced microglia. Eur J Pharmacol. 2012; 692:29-37.","DOI":"10.1016\/j.ejphar.2012.05.030"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Li J, Yu H, Yang C, Ma T, Dai Y. Therapeutic potential and molecular mechanisms of echinacoside in neurodegenerative diseases. Front Pharmacol. 2022; 13:841110.","DOI":"10.3389\/fphar.2022.841110"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Huang Z, Gong J, Lin W, Feng Z, Ma Y, Tu Y, Cai X, Liu J, Lv C, Lv X, Wu Q, Lu W, Zhao J, Ying Y, Li S, Ni W, Chen H. Catalpol as a component of rehmannia glutinosa protects spinal cord injury by inhibiting endoplasmic reticulum stress-mediated neuronal apoptosis. Front Pharmacol. 2022; 13:860757.","DOI":"10.3389\/fphar.2022.860757"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Lv C, Yuan X, Zeng HW, Liu RH, Zhang WD. Protective effect of cinnamaldehyde against glutamate-induced oxidative stress and apoptosis in PC12 cells. Eur J Pharmacol. 2017; 815:487-494.","DOI":"10.1016\/j.ejphar.2017.09.009"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Pan W, Su X, Bao J, Wang J, Zhu J, Cai D, Yu L, Zhou H. Open randomized clinical trial on JWSJZ decoction for the treatment of ALS patients. Evid-based Complement Altern Med. 2013; 2013:347525.","DOI":"10.1155\/2013\/347525"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Qi GY, Liu P, Gao BL. Shenqi fuzheng injection alleviates the transient worsening caused by steroids pulse therapy in treating myasthenia gravis. Evid-based Complement Altern Med. 2013; 2013:816829.","DOI":"10.1155\/2013\/816829"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Gu X, Zhou J, Zhou Y, Wang H, Si N, Ren W, Zhao W, Fan X, Gao W, Wei X, Yang J, Bian B, Zhao H. Huanglian jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer&apos;s disease progression based on the &apos;brain-gut&apos; axis through multiple integrated omics. Alzheimer&apos;s Res Ther. 2021; 13:44.","DOI":"10.1186\/s13195-021-00779-7"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Zhan K, Chen S, Ji L, Xu L, Zhang Y, Zhang Q, Dai Q, Wu S. Network pharmacology to unveil the mechanism of astragali radix in the treatment of lupus nephritis <i>via<\/i> PI3K\/AKT\/mTOR pathway. Sci Rep. 2024; 14:25983.","DOI":"10.1038\/s41598-024-77897-3"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Wang Y, Xiao J, Duan Y, Miao M, Huang B, Chen J, Cheng G, Zhou X, Jin Y, He J, Li Z, So KF. Lycium barbarum polysaccharide ameliorates Sj\u00f6gren&apos;s syndrome in a murine model. Mol Nutr Food Res. 2021; 65:e2001118.","DOI":"10.1002\/mnfr.202001118"},{"key":"105","unstructured":"105. Drug Clinical Trial Registration and Information Disclosure Platform. Shenrong Granules. <i>http:\/\/www.chinadrugtrials.org.cn\/clinicaltrials.searchlist.dhtml?keywords=CTR20240243<\/i> (accessed May 12, 2025)"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Guo F, Tang X, Zhang W, Wei J, Tang S, Wu H, Yang H. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example. Pharmacol Res. 2020; 160:105077.","DOI":"10.1016\/j.phrs.2020.105077"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Lv C, Wu X, Wang X, Su J, Zeng H, Zhao J, Lin S, Liu R, Li H, Li X, Zhang W. The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: A general template for research on TCMs. Sci Rep. 2017; 7:352.","DOI":"10.1038\/s41598-017-00535-8"},{"key":"108","unstructured":"108. National Health Commission. Notification on the release of the first list of rare diseases. <i>https:\/\/www.gov.cn\/zhengce\/zhengceku\/2018-12\/31\/content_5435167.htm<\/i> (accessed May 12, 2025)."},{"key":"109","doi-asserted-by":"crossref","unstructured":"119. Suh WJ, Seo Y, Jin C, Cho SY, Park SU, Jung WS, Moon SK, Park JM, Ko CN, Kwon S, Cho KH. Traditional East Asian herbal medicine for amyotrophic lateral sclerosis: A scoping review. Evid-based Complement Altern Med. 2021; 2021:5674142.","DOI":"10.1155\/2021\/5674142"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Guan J, Zhao Y, Wang T, Fu R. Traditional Chinese medicine for treating aplastic anemia. J Pharm Pharm Sci: Publ Can Soc Pharm Sci Soc Can Sci Pharm. 2023;26:11863.","DOI":"10.3389\/jpps.2023.11863"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Chen H, Wang X, Tang L, Pu Y, Ma Y, Ye H, Zhang J. Review of the efficacy and mechanisms of traditional Chinese medicine for treating multi-organ damage in wilson&apos;s disease. Drug Des Dev Ther. 2025; 19:2453-2471.","DOI":"10.2147\/DDDT.S515123"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Chen HT, Tung CH, Yu BH, Chang CM, Chen YC. Renal and survival benefits of seventeen prescribed Chinese herbal medicines against oxidative-inflammatory stress in systemic lupus erythematosus patients with chronic kidney disease: A real-world longitudinal study. Front Pharmacol. 2023; 14:1309582.","DOI":"10.3389\/fphar.2023.1309582"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Pan W, Chen X, Bao J, Bai Y, Lu H, Wang Q, Liu Y, Yuan C, Li W, Liu Z, Liu J, Zhu X, Qin B, Cai D, Zhou H. The use of integrative therapies in patients with amyotrophic lateral sclerosis in Shanghai, China. Evid-based Complement Altern Med: Ecam. 2013; 2013:613596.","DOI":"10.1155\/2013\/613596"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Peng A, Fan X, Zou L, Chen H, Xiang J. Trend of clinical trials of new drugs for rare diseases in China in recent 10 years. Orphanet J Rare Dis. 2023; 18:114.","DOI":"10.1186\/s13023-023-02713-6"},{"key":"115","unstructured":"115. National Institutes of Health, National Library of Medicine. Clinical Trials. <i>https:\/\/clinicaltrials.gov\/<\/i> (accessed May 12, 2025)."},{"key":"116","unstructured":"116. National Organization for Rare Disorders. Understanding Rare Disease <i>https:\/\/rarediseases.org\/understanding-rare-disease\/<\/i> (accessed May 12, 2025)."},{"key":"117","unstructured":"117. National Institutes of Biomedical Innovation, Health, and Nutrition. Laboratory of Rare Disease Information and Resource Library. <i>https:\/\/www.nibn.go.jp\/en\/activities\/disease-resources.html<\/i> (accessed May 12, 2025)."},{"key":"118","unstructured":"118. Japan Intractable Diseases Information Center. List of Designated Intractable Diseases. <i>https:\/\/www.nanbyou.or.jp\/entry\/5461<\/i> (accessed May 12, 2025)."},{"key":"119","unstructured":"119. Ministry of Health, Labour and Welfare of Japan. Act on Medical Care for Patients with Intractable Diseases. <i>https:\/\/www.mhlw.go.jp\/file\/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka\/0000060761.pdf<\/i> (accessed May 12, 2025)."},{"key":"120","unstructured":"120. Yicai Global. 70% of China&apos;s rare disease drugs have been added to medical insurance plan. <i>https:\/\/www.yicaiglobal.com\/news\/70-of-chinas-rare-disease-drugs-have-been-added-to-medical-insurance-plan<\/i> (accessed May 12, 2025)."},{"key":"121","unstructured":"121. World Health Organization. China and WHO deepen strategic partnership to lead global traditional medicine advancements. <i>https:\/\/www.who.int\/news\/item\/09-11-2024-china-and-who-deepen-strategic-partnership-to-lead-global-traditional-medicine-advancements<\/i> (accessed May 12, 2025)."},{"key":"122","unstructured":"122. World Health Organization. Beijing declaration calls for strengthened global collaboration on traditional medicine. <i>https:\/\/www.who.int\/news\/item\/23-12-2024-beijing-declaration-calls-for-strengthened-global-collaboration-on-traditional-medicine<\/i>(accessed May 12, 2025)."}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/14\/2\/14_2025.01028\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:30:31Z","timestamp":1749875431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/14\/2\/14_2025.01028\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2025.01028","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"article-number":"2025.01028"}}